0001104659-20-128061.txt : 20201120
0001104659-20-128061.hdr.sgml : 20201120
20201120173630
ACCESSION NUMBER: 0001104659-20-128061
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201120
FILED AS OF DATE: 20201120
DATE AS OF CHANGE: 20201120
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MOMTAZEE JAMES C
CENTRAL INDEX KEY: 0001209181
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39597
FILM NUMBER: 201333608
MAIL ADDRESS:
STREET 1: 2755 CAMPUS DRIVE, SUITE 240
CITY: SAN MATEO
STATE: CA
ZIP: 94403-2538
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Montes Archimedes Acquisition Corp
CENTRAL INDEX KEY: 0001819263
STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 724 OAK GROVE, SUITE 130
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: 212-446-4600
MAIL ADDRESS:
STREET 1: 724 OAK GROVE, SUITE 130
CITY: MENLO PARK
STATE: CA
ZIP: 94025
4
1
a4.xml
4
X0306
4
2020-11-20
0
0001819263
Montes Archimedes Acquisition Corp
MAAC
0001209181
MOMTAZEE JAMES C
724 OAK GROVE, SUITE 130
MENLO PARK
CA
94025
1
1
1
0
Chief Executive Officer
Class B common stock
2020-11-20
4
J
0
1232044
D
Class A common stock
1232044
10167956
I
By Patient Square Capital LLC
This Form 4 reflects the automatic surrender to the issuer of 1,285,637 of the issuer's shares of Class B common stock, par value $0.0001 per share, for no consideration by the Patient Square Capital LLC (the "Sponsor") pursuant to contractual arrangements with the issuer, triggered by the expiration of the option of the underwriter of the issuer's initial public offering to purchase additional units.
As described in the issuer's registration statement on Form S-1 (File No. 333-248802) under the heading "Description of Securities-Founder Shares", the shares of Class B common stock, par value $0.0001, will automatically convert into shares of Class A common stock, par value $0.0001, of the issuer at the time of the issuer's initial partnering transaction on a one-for-one basis, subject to adjustment for share splits, share capitalizations, reorganizations, recapitalizations and the like, and certain anti-dilution rights and have no expiration date.
The securities reported herein are held by the Sponsor. The reporting person controls the Sponsor, and as such has voting and investment discretion with respect to the securities held by the the Sponsor and may be deemed to have beneficial ownership of the securities held directly by the Sponsor. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose.
/s/ James C. Momtazee
2020-11-20